Literature DB >> 1698819

Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome.

L A Diaz1, H Ratrie, W S Saunders, S Futamura, H L Squiquera, G J Anhalt, G J Giudice.   

Abstract

Autoantibodies present in the sera of patients with bullous pemphigoid (BP) bind to the basement membrane zone of normal human skin and commonly recognize two epidermal proteins, the BP240 and BP180 antigens. Two BP antigen cDNA clones from a lambda gt11 human keratinocyte library have been identified on the basis of reactivity with a BP serum. The fusion protein (FP) produced by one clone immunoadsorbed autoantibodies, which specifically recognized the BP180 by antigen, showing no cross-reactivity with BP240 by immunoblot analysis. The FP produced by the second clone immunoadsorbed autoantibodies which specifically reacted with the BP240 epidermal antigen. Northern blot analysis demonstrated that the BP180 and BP240 antigens are encoded by distinct RNA transcripts with lengths of 6.0 and 8.5 kb, respectively. Immunoblot analysis of the BP180 lysogen extract identified a 135-kD FP which was recognized by 7 of 16 BP sera and 7 of 8 herpes gestationis sera. A rabbit antiserum prepared against the lysogenic BP180 FP specifically recognized the BP180 antigen from human epidermal extracts by immunoblotting, labeled the BMZ by indirect immunofluorescence, and bound to human epidermal hemidesmosomes by immuno-electron microscopy. These results indicate that the BP180 antigen recognized by BP and herpes gestationis autoantibodies is a unique hemidesmosomal polypeptide, distinguishable from the BP240 antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698819      PMCID: PMC296836          DOI: 10.1172/JCI114812

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  The transfection of epidermal keratin genes into fibroblasts and simple epithelial cells: evidence for inducing a type I keratin by a type II gene.

Authors:  G J Giudice; E Fuchs
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

2.  Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes.

Authors:  G E Westgate; A C Weaver; J R Couchman
Journal:  J Invest Dermatol       Date:  1985-03       Impact factor: 8.551

3.  Use of protein-bearing nitrocellulose as immunogen for in vitro production of monoclonal antibodies: application to myelin basic protein electrophoretically separated from a complex brain protein mixture.

Authors:  H Z Sheng; J Hoogenraad; P R Carnegie; C C Bernard
Journal:  Immunol Lett       Date:  1987-10       Impact factor: 3.685

4.  A 230-kD basic protein is the major bullous pemphigoid antigen.

Authors:  S Mueller; V Klaus-Kovtun; J R Stanley
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

5.  Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.

Authors:  J R Stanley; T Tanaka; S Mueller; V Klaus-Kovtun; D Roop
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

6.  Practical aspects of preparing phage and plasmid DNA: growth, maintenance, and storage of bacteria and bacteriophage.

Authors:  H Miller
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  Ultrastructural findings in bullous pemphigoid.

Authors:  B Giannotti; P Fabbri; E Panconesi
Journal:  J Cutan Pathol       Date:  1975       Impact factor: 1.587

8.  Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.

Authors:  R S Labib; G J Anhalt; H P Patel; D F Mutasim; L A Diaz
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

9.  Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence.

Authors:  P Bernard; L Didierjean; F Denis; J H Saurat; J M Bonnetblanc
Journal:  J Invest Dermatol       Date:  1989-02       Impact factor: 8.551

10.  Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen.

Authors:  W C Earnshaw; K F Sullivan; P S Machlin; C A Cooke; D A Kaiser; T D Pollard; N F Rothfield; D W Cleveland
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

View more
  64 in total

Review 1.  Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases.

Authors:  J Uitto; A M Christiano
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis.

Authors:  K A Spivey; I Chung; J Banyard; I Adini; H A Feldman; B R Zetter
Journal:  Oncogene       Date:  2011-10-03       Impact factor: 9.867

3.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

4.  Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332.

Authors:  F Van den Bergh; S L Eliason; G J Giudice
Journal:  Matrix Biol       Date:  2010-10-26       Impact factor: 11.583

5.  [Postpartum persistent herpes gestationis. A therapeutic challenge].

Authors:  S Hanneken; N Hodzic-Avdagic; N J Neumann; T Ruzicka; D Bruch-Gerharz
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

Review 6.  The role of topical corticosteroids in bullous pemphigoid in the elderly.

Authors:  Pascal Joly; Juliette Fontaine; Jean-Claude Roujeau
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  The NC16A domain of collagen XVII plays a role in triple helix assembly and stability.

Authors:  Françoise Van den Bergh; Chang-Ling Fu; Monica Olague-Marchan; George J Giudice
Journal:  Biochem Biophys Res Commun       Date:  2006-10-05       Impact factor: 3.575

8.  Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.

Authors:  A Ishiko; H Shimizu; A Kikuchi; T Ebihara; T Hashimoto; T Nishikawa
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.

Authors:  M Ståhle-Bäckdahl; M Inoue; G J Guidice; W C Parks
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  The role of complement in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; S J Swartz; J A Fairley; G O Till; J L Troy; L A Diaz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.